ISPC vs SRPT · rev $9.3M vs rev $1.90B
iSpecimen Inc (ISPC) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
ISPC currently screens at market cap $4.4M. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the ISPC and SRPT stock pages for the full models.
Not investment advice.